Literature DB >> 23858310

Hip arthrosis and surgical intervention: what and when?

Massimo Innocenti1, Lorenzo Nistri, Marco Biondi, Armando Del Prete, Marco Giorgini, Armando Macera, Stefano Soderi.   

Abstract

Osteoarthritis of the hip is a common pathology and involves forms of disability and need for treatments that affect the quality of life of patients and their families, and in general of the whole society. It should be considered as such degenerative joint disease is increasing as the increase in life expectancy and musculoskeletal trauma, the latter responsible for secondary forms of osteoarthritis. The treatment of osteoarthritis of the hip has changed a lot over the years, since the earlier diagnosis and, before, with prevention through proper lifestyle. More in-depth knowledge of the biology of the tissues involved, first of all hyaline cartilage, has lead to non-surgical treatments such as infiltration with hyaluronic acid (viscosupplementation) and autologous growth factors derived from platelets (platelet rich plasma). Surgical therapy with prosthetic replacement is finally a choice to share with the patient based on pain and functional limitation, bearing in mind always the best technology and tribology and the possibility of less invasive surgical access, while recognizing that there are not still eternal prosthesis. Of particular importance then is the age of the patient. There are also other types of surgery (hip arthroscopy, forage) for other pathologies of the hip which can be resolutive, or, in a sense, can delay the arrival to the prosthetic replacement. We will discuss below the decision-making process that leads the surgeon with the patient to the surgery option.

Entities:  

Keywords:  growth factors; hip arthroplasty; hip arthrosis; viscosupplementation

Year:  2013        PMID: 23858310      PMCID: PMC3710009          DOI: 10.11138/ccmbm/2013.10.1.041

Source DB:  PubMed          Journal:  Clin Cases Miner Bone Metab        ISSN: 1724-8914


  15 in total

1.  Validity and reliability of Swedish WOMAC osteoarthritis index: a self-administered disease-specific questionnaire (WOMAC) versus generic instruments (SF-36 and NHP).

Authors:  P Söderman; H Malchau
Journal:  Acta Orthop Scand       Date:  2000-02

2.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

Review 3.  Return to preinjury activity levels after surgical management of femoroacetabular impingement in athletes.

Authors:  Hussain Alradwan; Marc J Philippon; Forough Farrokhyar; Raymond Chu; Daniel Whelan; Mohit Bhandari; Olufemi R Ayeni
Journal:  Arthroscopy       Date:  2012-07-13       Impact factor: 4.772

4.  Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation.

Authors:  W H Harris
Journal:  J Bone Joint Surg Am       Date:  1969-06       Impact factor: 5.284

5.  Overview: maintaining outcomes for total hip arthroplasty. The past, present, and future.

Authors:  M A Ritter; M J Albohm
Journal:  Clin Orthop Relat Res       Date:  1997-11       Impact factor: 4.176

6.  Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee.

Authors:  N Bellamy; W W Buchanan; C H Goldsmith; J Campbell; L W Stitt
Journal:  J Rheumatol       Date:  1988-12       Impact factor: 4.666

7.  Predicting quality-of-life outcomes following total joint arthroplasty. Limitations of the SF-36 Health Status Questionnaire.

Authors:  F X McGuigan; W J Hozack; L Moriarty; K Eng; R H Rothman
Journal:  J Arthroplasty       Date:  1995-12       Impact factor: 4.757

8.  Indications for total hip and total knee arthroplasties. Results of orthopaedic surveys.

Authors:  C A Mancuso; C S Ranawat; J M Esdaile; N A Johanson; M E Charlson
Journal:  J Arthroplasty       Date:  1996-01       Impact factor: 4.757

9.  Charnley total hip arthroplasty with cement. Minimum twenty-five-year follow-up.

Authors:  J J Callaghan; J C Albright; D D Goetz; J P Olejniczak; R C Johnston
Journal:  J Bone Joint Surg Am       Date:  2000-04       Impact factor: 5.284

Review 10.  Total hip replacement.

Authors: 
Journal:  NIH Consens Statement       Date:  1994 Sep 12-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.